Sitagliptin BEKER® is a DPP-4 inhibitor (dipeptidylpeptidase 4 inhibitor) .It is indicated for the treatment of non-insulin-dependent diabetes as an adjunct to diet and exercise, either as monotherapy or in combination with other therapies. antidiabetic drugs.
| DCI | SITAGLIPTINE |
|---|---|
| Dosage | 50 mg |
| Trade name | SITAGLIPTINE BEKER ® |
| Name of the originator | Januvia |
| Presentation | 30 tablets |
| Specialty | Métabolisme – ADO |
